FluroTech Ltd. Announces Application for Resumption of Trading, AGM Deficiency Update, and CFO Appointment
Toronto, Ontario--(Newsfile Corp. - January 9, 2026) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce that it has applied to the NEX board of the TSX Venture Exchange ("TSXV") for the resumption of trading of its common shares. The Company's shares were halted on December 20, 2023, pending completion of a proposed transaction with Great Slave Helicopters 2018 Ltd. ("GS Heli"). The definitive agreement with GS Heli was terminated on October 7
2026-01-09 5:00 PM EST | FluroTech Ltd.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - January 8, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-5 reverse stock split of the Company's common shares effective January 12, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on December 23, 2025 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of marke
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-01-08 8:30 AM EST | Akanda Corp
MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million
Saskatoon, Saskatchewan--(Newsfile Corp. - January 8, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce a non-brokered private placement of up to 4,000,000 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of up to $2,000,000 (the "LIFE Offering"). Each Unit will consist of (i) one common share of the Company (a "Share"); and (ii)
Agriculture, Biotechnology, Cannabis, Cannabis Breeder
2026-01-08 7:00 AM EST | MustGrow Biologics Corp.
1CM Announces CFO Change
Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce that its board of directors has appointed Antony Pramoth as Chief Financial Officer of the Company. Mr. Pramoth succeeds Harshil Chovatiya, who has served as the Company's Chief Financial Officer since February 24, 2023, effective immediately. Mr. Pramoth has been with 1CM since October 2023. The Company is pleased to promote Mr.
Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-01-07 5:21 PM EST | 1CM Inc.
SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan
Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased to announce that SNDL has completed the acquisition of 5 cannabis retail stores located in Alberta and Saskatchewan from 1CM. The transaction represents the completion of the first closing pursuant to the amended and restated arrangement agreement dated December 15, 2025 (the "
Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-01-07 4:43 PM EST | 1CM Inc.
Beckett's Kicks Off Multi-Channel Dry January Campaign Across Retail, Subscription Services, and Influencer Partnerships
Ontario and Los Angeles, California--(Newsfile Corp. - January 6, 2026) - Beckett's Inc. (CSE: BKTS) (OTCQB: BKTSF), a fast-growing non-alcoholic beverage brand has launched a national Dry January initiative spanning major retail, subscription, and influencer channels. The month-long campaign includes featured promotions at Total Wine & More, Walmart.com, Amazon.com, national non-alcoholic subscription service Raising the Bar, Los Angeles bottle shop Burden of Proof, along w
Food / Beverages, Cannabis, Health
2026-01-06 7:30 AM EST | Becketts Inc.
Illicit Brand Parent Company, S1 Enterprises, Launches Largest Employee Stock Ownership Plan in U.S. Cannabis Industry
Kansas City, Missouri--(Newsfile Corp. - January 5, 2026) - S1 Enterprises, the parent company of the Illicit brand and affiliated cannabis operations in Missouri and New Jersey, has successfully closed on its sale to an Employee Stock Ownership Plan (ESOP), marking a major milestone for employee ownership in the regulated cannabis industry. This transaction represents the largest ESOP completed in the cannabis sector to date, reflecting both the scale of the company and growing institu
Cannabis, Cannabis Dispensary, Cannabis Extractor, Cannabis Manufacturer
2026-01-05 1:04 PM EST | Illicit Gardens
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has closed the previously announced (see press release dated October 31, 2025) acquisition (the "Transaction") of limited partnership units of Canurta Limited Partnership ("Canurta"), the p
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2026-01-05 8:00 AM EST | PharmaDrug Inc.
Simply Solventless Announces Appointment of Seasoned Executive Charles Vennat to Board of Directors
Calgary, Alberta--(Newsfile Corp. - January 5, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce the appointment of seasoned executive Charles Vennat to its board of directors. Charles is an accomplished CEO and corporate director with significant experience leading complex manufacturing, consumer packaged goods and regulated cannabis businesses. Charles currently serves as President & CEO of CMI Mulching. Prior thereto,
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-01-05 7:05 AM EST | Simply Solventless Concentrates Ltd.
CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition
Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the launch of a national outreach and partnership initiative designed to capitalize on the accelerating federal momentum toward moving cannabis from Schedule I to Schedule III through the ongoing rescheduling rulemaking process. On December 18, 2025, a Presidential Exe
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-01-05 7:00 AM EST | Cannabis Bioscience International Holdings
Early Warning News Release of Jason T. Nguyen
Vancouver, British Columbia--(Newsfile Corp. - January 2, 2026) - Jason T. Nguyen announces that he has filed an early warning report regarding his updated securityholdings of securities of Vext Science, Inc. (the "Issuer"). The Issuer's head office is located at 4152 N. 39th Avenue Phoenix, Arizona, USA 85019. On December 24, 2025, Mr. Nguyen entered into two Share Purchase Agreements, pursuant to which Mr. Nguyen agreed to sell an aggregate of 20,340 Class A common shares in th
2026-01-02 5:00 PM EST | Jason T. Nguyen
Elixxer Announces Results of Annual and Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - December 30, 2025) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company) is pleased to announce the results of its annual and special meeting of shareholders (the "Meeting") held on December 30, 2025. A total of 3,798,208 shares were voted at the Meeting in person or by proxy, representing 33.50% of the votes attached to all of the Company's issued and outstanding common shares. All matters submitted to shareholders for approval as set out
2025-12-30 5:30 PM EST | Elixxer Ltd.
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
Ontario and Rionegro, Colombia--(Newsfile Corp. - December 30, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced revocation of FFCTO and relate
2025-12-30 7:30 AM EST | PharmaCielo Ltd.
CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways
Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that it is pursuing a new patent for an investigational therapy designed to address opioid addiction, a condition that continues to claim tens of thousands of lives each year in the United States. According to U.S. public health data, more than 700,000 people have died
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-12-29 7:00 AM EST | Cannabis Bioscience International Holdings
Entheon Announces Letter of Intent with Nutravisor Inc.
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered into a binding Letter of Intent (the "LOI") dated December 18, 2025, with Nutravisor Inc. ("Nutravisor") whereby Entheon will acquire all of the issued and outstanding common shares of Nutravisor (the "Proposed Transaction"). Upon completion of the Proposed T
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2025-12-22 9:30 AM EST | Entheon Biomedical Corp.
CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities
Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications that President Donald Trump will support federal actions that advance the rescheduling of marijuana from Schedule I to Schedule III. The development is widely regarded as one of the most consequential policy shifts in nearly two decades of national debate. After eighte
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-12-22 7:00 AM EST | Cannabis Bioscience International Holdings
Steep Hill Provides Update on Transaction with Good Purpose Investments
Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to provide an update on its ongoing transaction with Good Purpose Investments Inc. ("Good Purpose"). Good Purpose is a privately held British Columbia corporation that operates a business engaged in the manufacturing, marketing, and distribution of textiles made from recycled plastics under the trade name "Waste2Wear." Through its subs
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-12-19 5:30 PM EST | Steep Hill Inc.
Herbal Dispatch CEO Philip Campbell Weighs in on Global Implications of USA Cannabis Reclassification to Schedule III
Vancouver, British Columbia--(Newsfile Corp. - December 19, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") a leading Canadian cannabis e-commerce platform specializing in small-batch craft cannabis, today shared insights from CEO Philip Campbell regarding President Trump's landmark decision to shift cannabis from Schedule I to Schedule III under the U.S. Controlled Substances Act. "This development stands a
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-12-19 9:51 AM EST | Herbal Dispatch Inc.
Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States
Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") applauds the recent reports that US President Donald Trump and his administration are considering changes and the reclassification of federal cannabis policy in the USA, including potential rescheduling of cannabis from Schedule I to Schedule III. Schedule III drugs are considered to have a medical value and a lower abuse potential as defined by the Drug Enforcement Administra
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-12-18 7:30 AM EST | Akanda Corp
MustGrow: CEO Letter to Shareholders 2025
Saskatoon, Saskatchewan--(Newsfile Corp. - December 18, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to issue a letter to shareholders from Corey Giasson, MustGrow's President and CEO. Dear MustGrow shareholders and stakeholders, I hope everyone is well and ready to enjoy a peaceful and festive holiday season with family and friends. I am writing this letter to share our excitement in what
Agriculture, Biotechnology, Cannabis, Cannabis Breeder
2025-12-18 7:00 AM EST | MustGrow Biologics Corp.